CHX Technologies is focused on improving oral health as part of chronic disease management.Our drug, Prevora, is approved in Canada, Ireland, & the United Kingdom and the EMA has issued a positive opinion for MR in the EU. For years, Prevora has shown it reliably, safely & affordably improves oral health in high risk adults. This is important to better management of diabetes, COPD, hypertension, cognitive decline, CKD and heart disease. CHX has proprietary models for integrating Prevora into medical care.